ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYALTRBGCZEEHUPLSKBAHRIS..MTNORSMESMMAKHTNMDGE........*X0009010-RPUB024770629A120260708EP24860910.92024082820260220enenen202363579413 P20230829US2026070820262820260708202628A61K 31/395 20060101AFI20250308BHEP A61K 31/397 20060101ALI20250308BHEP A61K 31/02 20060101ALI20250308BHEP A61K 31/397 20130101 FI20250324BHEP A61K 9/0019 20130101 LI20250512BHEP A61K 9/1075 20130101 LI20250512BHEP A61K 9/127 20130101 LI20250512BHEP A61K 9/10 20130101 LI20250512BHEP A61K 47/44 20130101 LA20250512BHEP A61K 47/10 20130101 LA20250512BHEP A61K 47/32 20130101 LA20250512BHEP A61K 47/24 20130101 LA20250512BHEP A61K 47/06 20130101 LA20250512BHEP dePARENTERALE FORMULIERUNGEN VON CB1-INHIBITOREN UND VERFAHREN ZUR VERWENDUNGenPARENTERAL FORMULATIONS OF CB1 INHIBITORS AND METHODS OF USEfrFORMULATIONS PARENTÉRALES D'INHIBITEURS DE CB1 ET PROCÉDÉS D'UTILISATIONAnebulo Pharmaceuticals, Inc.102042189P13896WOEP1017 Ranch Road 620 South Suite 107Lakeway, Texas 78734USCUNDY, Kenneth C.Lakeway, Texas 78734USCOURTNEY, MargaretLondon W1W 7LTGBVAN HOOGEVEST, PeterLakeway, Texas 78734USBrand Murray Fuller LLP10176307850 Eastcastle StreetLondon W1W 8EAGBALATBEBGCHCYCZDEDKEEESFIFRGBGRHRHUIEISITLILTLULVMCMEMKMTNLNOPLPTRORSSESISKSMTRBAGEKHMAMDTNUS202404414420240828enWO202504954420250306202510